Inventor
VALCARCE LOPEZ MARIA CARMEN
US20 patents
⚠️ This page may combine multiple inventors who share the name “VALCARCE LOPEZ MARIA CARMEN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
VTV THERAPEUTICS LLC
14 patentsUS9968613B2May 15, 2018
Use of a ppar-delta agonist for reducing loss of muscle strength, muscle mass, or type I muscle fibers in an immobilized limb
VTV THERAPEUTICS LLC12 citations92
US9487493B2Nov 8, 2016
Use of a PPAR-delta agonist for treating muscle atrophy
VTV THERAPEUTICS LLC17 citations92
US10363244B2Jul 30, 2019
Compositions comprising metformin and a glucokinase activator
VTV THERAPEUTICS LLC5 citations84
US10064846B2Sep 4, 2018
Use of metformin in combination with a glucokinase activator and compositions comprising metformin and a glucokinase activator
VTV THERAPEUTICS LLC6 citations84
US9855251B2Jan 2, 2018
Use of metformin in combination with a glucokinase activator and compositions comprising metformin and a glucokinase activator
VTV THERAPEUTICS LLC7 citations84
US10456406B2Oct 29, 2019
Use of a PPAR-δ agonist for reducing loss of muscle strength, muscle mass, or type I muscle fibers in an immobilized limb
VTV THERAPEUTICS LLC9 citations83
US10952993B2Mar 23, 2021
Therapeutic uses of glucokinase activators in combination with insulin or insulin analogs
VTV THERAPEUTICS LLC5 citations82
US10980861B2Apr 20, 2021
Glucokinase activator compositions for the treatment of diabetes
VTV THERAPEUTICS LLC4 citations81
US10588943B2Mar 17, 2020
Glucokinase activator compositions for the treatment of diabetes
VTV THERAPEUTICS LLC5 citations81
US10004782B2Jun 26, 2018
Glucokinase activator compositions for the treatment of diabetes
VTV THERAPEUTICS LLC10 citations81
US11096946B2Aug 24, 2021
Use of a PPAR-δ agonist for reducing loss of muscle strength, muscle mass, or type I muscle fibers in an immobilized limb
VTV THERAPEUTICS LLC2 citations72
US11974989B2May 7, 2024
Therapeutic uses of glucokinase activators in combination with insulin or insulin analogs
VTV THERAPEUTICS LLC1 citations71
US11833136B2Dec 5, 2023
Therapeutic uses of glucokinase activators in combination with insulin or insulin analogs
VTV THERAPEUTICS LLC1 citations71
US9717710B2Aug 1, 2017
Treatment of mild and moderate Alzheimer's disease
VTV THERAPEUTICS LLC5 citations68
NOVO NORDISK AS
4 patentsUS7598391B2Oct 6, 2009
Heteroaryl-ureas and their use as glucokinase activators
NOVO NORDISK AS14 citations92
USRE45183EOct 7, 2014
Heteroaryl-ureas and their use as glucokinase activators
NOVO NORDISK AS7 citations83
US7872139B2Jan 18, 2011
Heteroaryl-ureas and their use as glucokinase activators
NOVO NORDISK AS10 citations83
US7851636B2Dec 14, 2010
Heteroaryl-ureas and their use as glucokinase activators
NOVO NORDISK AS8 citations83